Apoptotic cues from the extracellular matrix: regulators of angiogenesis (Q35603378)

9 August 2017

1 reference

title

Apoptotic cues from the extracellular matrix: regulators of angiogenesis (English)

1 reference

9 August 2017

0 references

0 references

1 reference

Dwayne G Stupack

1

1 reference

PubMed ID

14663480

9 August 2017

David A Cheresh

series ordinal

2

1 reference

PubMed ID

14663480

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

22

1 reference

9 August 2017

56

1 reference

9 August 2017

9022-9029

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207110

9 August 2017

0 references

cites work

Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Development of inflammatory angiogenesis by local stimulation of Fas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Induction of the angiogenic phenotype by Hox D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Integrin alpha(v)beta(3)-mediated activation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Anchorage-dependent ERK signaling--mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Anticancer drug targets: approaching angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Homeobox B3 promotes capillary morphogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Signaling through focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Essential role for caspase-8 in transcription-independent apoptosis triggered by p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

1 reference

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Vitronectin decreases microvascular endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207110

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207110

1 reference

9 August 2017

1 reference

PubMed ID

14663480